Acrivon Therapeutics所有资讯

Acrivon Therapeutics | 4：持股变动声明-高管 Miller Mary

04/20 04:15

Acrivon Therapeutics | 4：持股变动声明-董事 RA CAPITAL MANAGEMENT, L.P.

04/16 04:20

Acrivon Therapeutics | 4：持股变动声明-股东 PERCEPTIVE ADVISORS LLC

04/15 20:58

Acrivon Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Perceptive Advisors LLC(17.4%),Joseph Edelman(17.4%)等

04/15 20:23

Acrivon Therapeutics | SC 13D/A：超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(27.1%),Peter Kolchinsky(27.1%)等

04/12 04:22

Acrivon Therapeutics | 4：持股变动声明-董事 Palani Santhosh

03/07 05:36

Acrivon Therapeutics | 3：首次持股声明-董事 Palani Santhosh

03/07 05:31

Acrivon Therapeutics | 4：持股变动声明-高管 Masson Kristina

02/17 06:19

Acrivon Therapeutics | 4：持股变动声明-高管 Miller Mary

02/17 06:18

Acrivon Therapeutics | 4：持股变动声明-高管 Holm-Jorgensen Rasmus

02/17 06:17

Acrivon Therapeutics | 4：持股变动声明-高管 Devroe Eric

02/17 06:13

Acrivon Therapeutics | 4：持股变动声明-高管 Gamelin Erick

02/17 06:13

Acrivon Therapeutics | 4：持股变动声明-高管 Blume-Jensen Peter

02/17 06:08

Acrivon Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Perceptive Advisors LLC(13.6%),Joseph Edelman(13.6%)等

02/15 06:37

Acrivon Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Citadel Advisors LLC(7.4%),Citadel Advisors Holdings LP(7.4%)等

02/15 06:02

Acrivon Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Marshall Wace North America L.P.(2.7%)

02/14 22:57

Acrivon Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Sands Capital Life Sciences Pulse Fund II, L.P.(7.4%),Sands Capital Ventures, LLC(7.4%)等

02/14 04:45

Acrivon Therapeutics | 4：持股变动声明-董事 Magovcevic-Liebisch Ivana

02/10 05:41

Acrivon Therapeutics | 3：首次持股声明-董事 Magovcevic-Liebisch Ivana

02/10 05:36

Acrivon Therapeutics | 4：持股变动声明-高管 Miller Mary

01/19 13:00